Fmoc-(R)-3-Amino-4-(2-fluoro-phenyl)-butyric acid, 97%, 1g

2-Methyl-2H-indazol-5-ol, 97%, 100mg

5-(4-(isopropylthio)benzyl)-1,3,4-oxadiazol-2-amine, 95.0%, 500mg

2-chloro-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)acetamide, 250mg

2,4-Dimethoxy-6-methylbenzaldehyde, 98%, 5g

2-Amino-2-(3-chloropyridin-4-yl)ethanol hydrochloride, 97.0%, 250mg

2,4,6-Trichloropyrido[3,4-d]pyrimidine, 95%, 250mg

METHYL 1H-PYRAZOLO[4,3-B]PYRIDINE-5-CARBOXYLATE, 95%, 250mg

ROTI®Cell PBS, 500 ml

(R)-2-((tert-butoxycarbonyl)amino)-4-(4-fluorophenyl)butanoic acid, 98%, 1g

3-Amino-4-fluoro-1-methylindazole, 95.0%, 5g

tert-Butyl 4-formylbenzoate, 95.0%, 1g

2-(2-IMINO-4,5,6,7-TETRAHYDROBENZO[D]THIAZOL-3(2H)-YL)-1-(4-NITROPHENYL)ETHANONE HYDROBROMIDE, 98.0%, 1g